C4 Therapeutics, Inc. is led by Andrew Hirsch, who serves as the President and Chief Executive Officer. He manages the biopharmaceutical enterprise's overarching corporate strategy, operational execution, and clinical pipeline progression in the field of targeted protein degradation therapeutics. (Note: If referring to the energy drink brand C4, the parent company Nutrabolt is led by CEO Doss Cunningham).